Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Total Assets

Bristol-Myers Squibb Company Total Assets Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Total Assets from 2010 to 2020.
  • Bristol-Myers Squibb Company Total Assets for the quarter ending September 09, 2020 was $125,536m a -3.51% decrease of -4,408m year over year
  • Bristol-Myers Squibb Company Total Assets for the last 12 months ending September 09, 2020 was $125,536m a -3.51% decrease of -4,408m year over year
  • Bristol-Myers Squibb Company Annual Total Assets for 2019 was $129,944m a 73.08% increase of 94,958m from 2018
  • Bristol-Myers Squibb Company Annual Total Assets for 2018 was $34,986m a 4.10% increase of 1,435m from 2017
  • Bristol-Myers Squibb Company Annual Total Assets for 2017 was $33,551m a -0.46% decrease of -156m from 2016
Other Balance Sheet Metrics:
  • Bristol-Myers Squibb Company Other Liabilities for the quarter ending September 09, 2018 was $4,603m a -12.23% decrease of -563m year over year
  • Bristol-Myers Squibb Company Total Equity for the quarter ending December 12, 2018 was $13,750m a 6.14% increase of 844m year over year
View Chart On Koyfin

Quarterly BMY Total Assets Data

09/2020$125,536m
06/2020$128,076m
03/2020$129,285m
12/2019$129,944m
09/2019$57,433m
06/2019$55,163m
03/2019$34,834m
12/2018$34,986m
09/2018$33,734m
06/2018$32,641m

Annual BMY Total Assets Data

2019$129,944m
2018$34,986m
2017$33,551m
2016$33,707m
2015$31,748m
2014$33,749m
2013$38,592m
2012$35,897m
2011$32,970m
2010$31,076m